
Kirsten Sundby Hall
- Head of section, oncologist; PhD
- +47 22 93 49 85
Curriculum vitae
Name: | Kirsten Sundby Hall |
Date of birth: | 27.07.51 |
Private address: | Kristian Kølles v 8 1367 SNARØYA |
- 1980: Medical doctor at the University of Oslo
- 1991: Thesis, PhD: Contributions to the treatment of Primary Liver Cancer. 4`- Epidoxurubicin and cisplatin studied in hepatocarcinoma cell cultures and in partially hepatectomized rats.
- 1983 86: Resident at the Norwegian Radium Hospital
- 1986 94: Research fellow and resident at the Department of Clinical Pharmacology and the Department of Clinical Chemistry, The National Hospital, Rikshospitalet, Oslo
- 1994 96: Resident at the Norwegian Radium Hospital
- From 1996: Senior consultant at The Norwegian Radium Hospital
- From 01.04.00: Head, Sarcoma Programme, The Norwegian Radium Hospital
- From 01.04.00: Secretary of the Scandinavian Sarcoma Group (SSG)
- From 2000: Member of the steering comittee of the Norwegian Sarcoma Group and the National Centre of Competence for Sarcomas
- Sept 2001: Opponent at defence of doctorial thesis at University of Oslo: Cand. Med. Lars Norum : Serum markers in breast cancer, with emphasis on MUC1 . 10-11. 09. 2001
- From 2003: Principal supervisor for research fellow cand.med. Liv Hege Aksnes on a doctorial thesis: Quality of life and long-term-morbidity among survivors after multimodal treatment for Ewing`s sarcoma and osteosarcoma.
- Autumn 2003 and spring 2004: Master of Health administration program (60 credits) at The Department of Health Management and Health Economics, University of Oslo
Publications 2022
Fibrinogen-like protein 2 in gastrointestinal stromal tumour
J Cell Mol Med, 26 (4), 1083-1094
DOI 10.1111/jcmm.17163, PubMed 35029030
Responding to child and adolescent-to-parent violence and abuse from a distance: Remote delivery of interventions during Covid-19
Child Soc (in press)
DOI 10.1111/chso.12622, PubMed 36247928
Publications 2021
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol, 33 (1), 20-33
DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Eur J Cancer, 151, 150-158
DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
Lower-luminosity Obscured AGN Host Galaxies Are Not Predominantly in Major-merging Systems at Cosmic Noon
Astrophys. J., 919 (2), 129
DOI 10.3847/1538-4357/ac12c8
Publications 2020
Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
Sarcoma, 2020, 1814394
DOI 10.1155/2020/1814394, PubMed 33082706
Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
Clin Sarcoma Res, 10 (1), 22
DOI 10.1186/s13569-020-00145-5, PubMed 33292545
Publications 2018
Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
J Bone Oncol, 14, 002-2
DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
J Surg Oncol, 118 (1), 246-247
DOI 10.1002/jso.25137, PubMed 30208205
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
JAMA Oncol, 4 (9), e180219
DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
[Not Available]
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
Ann Surg Oncol, 25 (5), 1133-1139
DOI 10.1245/s10434-018-6353-5, PubMed 29435684
Publications 2017
Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
Acta Oncol, 56 (3), 479-483
DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
Acta Oncol, 56 (10), 1317-1323
DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
Br J Cancer, 116 (9), 1195-1202
DOI 10.1038/bjc.2017.82, PubMed 28334729
Publications 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Lancet Oncol, 17 (10), 1396-1408
DOI 10.1016/S1470-2045(16)30214-5, PubMed 27569442
Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
Clin Sarcoma Res, 6, 2
DOI 10.1186/s13569-016-0042-6, PubMed 26913180
Publications 2015
Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient
Sarcoma, 2015, 516843
DOI 10.1155/2015/516843, PubMed 25784831
Post-relapse survival in patients with Ewing sarcoma
Pediatr Blood Cancer, 62 (6), 994-9
DOI 10.1002/pbc.25388, PubMed 25585917
[A boy with a wound on his finger that would not heal]
Tidsskr Nor Laegeforen, 135 (5), 445-8
DOI 10.4045/tidsskr.14.0759, PubMed 25761032
A boy with a wound on his finger that would not heal
Tidsskr. Nor. Laegeforen., 135 (5), 444-447
Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
Mol Oncol, 9 (6), 1129-39
DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404
Publications 2014
[A woman in her 50s with heavy breathing and hypotension]
Tidsskr Nor Laegeforen, 134 (18), 1758-61
DOI 10.4045/tidsskr.13.1110, PubMed 25273250
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
Cancer, 120 (15), 2325-33
DOI 10.1002/cncr.28669, PubMed 24737415
Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
Acta Oncol, 53 (9), 1180-7
DOI 10.3109/0284186X.2014.899433, PubMed 24697744
Publications 2013
Incidence and mortality of second sarcomas - a population-based study
Eur J Cancer, 49 (15), 3292-302
DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study
Pediatr Blood Cancer, 61 (5), 840-5
DOI 10.1002/pbc.24868, PubMed 24254749
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
Neuro Oncol, 16 (2), 320-2
DOI 10.1093/neuonc/not230, PubMed 24311631
Publications 2012
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
Br J Clin Pharmacol, 73 (1), 106-14
DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
Neuro Oncol, 15 (2), 135-47
DOI 10.1093/neuonc/nos287, PubMed 23161774
Publications 2011
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
Acta Orthop, 82 (2), 211-6
DOI 10.3109/17453674.2011.566141, PubMed 21434784
Publications 2010
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
J Clin Oncol, 28 (9), 1573-82
DOI 10.1200/JCO.2009.24.8989, PubMed 20159821
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
DOI 10.1016/j.ijrobp.2010.07.037, PubMed 20933339
Multimodal treatment of osteogenic sarcoma of the jaw
Skull Base, 20 (3), 207-12
DOI 10.1055/s-0029-1246221, PubMed 21318040
DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
Acta Oncol, 50 (1), 148-50
DOI 10.3109/0284186X.2010.516273, PubMed 21110775
Publications 2009
Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
Acta Oncol, 48 (8), 1165-72
DOI 10.3109/02841860903032809, PubMed 19863225
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
Neuro Oncol, 11 (5), 514-28
DOI 10.1215/15228517-2008-127, PubMed 19182148
Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
Cancer Treat Res, 152, 509-15
DOI 10.1007/978-1-4419-0284-9_30, PubMed 20213412
Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
Acta Orthop., 80 334, 52-59
Small round cell sarcomas
Semin Oncol, 36 (4), 338-46
DOI 10.1053/j.seminoncol.2009.06.006, PubMed 19664494
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
Acta Orthop., 80 334, 60-66
Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
Acta Orthop., 80, 75-78
Publications 2008
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
Acta Oncol, 47 (8), 1475-82
DOI 10.1080/02841860802047387, PubMed 18607853
Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study
Int J Radiat Oncol Biol Phys, 71 (4), 1196-203
DOI 10.1016/j.ijrobp.2007.11.023, PubMed 18207661
Publications 2007
Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
Support Care Cancer, 15 (9), 1087-96
DOI 10.1007/s00520-007-0227-x, PubMed 17347843
Publications 2006
Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience
Acta Oncol, 45 (1), 38-46
DOI 10.1080/02841860500466624, PubMed 16464794
Publications 2004
Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
Cancer, 100 (10), 2233-9
DOI 10.1002/cncr.20254, PubMed 15139069
Havets hemmeligheter
Damm, [Oslo], 48 s.
BIBSYS 041442822, ISBN 82-04-09688-7
Publications 2002
[Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]
Tidsskr Nor Laegeforen, 122 (21), 2089-94
PubMed 12555642
Publications 1991
Contributions to the treatment of primary liver cancer: 4'-epidoxorubicin and cisplatin studied in hepatocarcinoma cell cultures and in partially hepatectomized rats
Norwegian cancer society, Department of clinical pharmacology and Institute of clinical biochemistry, Rikshospitalet, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 911427597, ISBN 82-7633-005-3